Vineis P, Avanzi G C, Giovinazzo B, Ponzio G, Cambrin G R, Ciccone G
Dipartimento di Scienze Biomediche e Oncologia Umana, Università di Torino.
Tumori. 1990 Aug 31;76(4):350-2. doi: 10.1177/030089169007600409.
In a pilot study, 57 patients affected by leukemias or myelodysplastic syndromes were interviewed to identify potential exposure to organic solvents. Cytogenetic analyses were performed in 40 of the 57 patients. Unlike previous investigations, no association was found between the occurrence of chromosomal abnormalities and exposure to organic solvents. An original finding was a strong association between solvent exposure and myelodysplastic disorders (4 certainly exposed and 1 possibly exposed out of 11 patients). Such an observation warrants confirmation from case-control studies.
在一项初步研究中,对57名白血病或骨髓增生异常综合征患者进行了访谈,以确定其是否有有机溶剂接触史。对这57名患者中的40名进行了细胞遗传学分析。与之前的研究不同,未发现染色体异常的发生与有机溶剂接触之间存在关联。一项新发现是溶剂接触与骨髓增生异常疾病之间存在强关联(11名患者中有4名肯定接触过,1名可能接触过)。这一观察结果有待病例对照研究加以证实。